SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001013762-23-000785
Filing Date
2023-10-03
Accepted
2023-10-03 09:51:37
Documents
2
Period of Report
2023-09-27

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 4886
2 POWER OF ATTORNEY ea186192-ex24_virpax.htm EX-24 5762
  Complete submission text file 0001013762-23-000785.txt   12073
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Issuer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1055 WESTLAKES DRIVE SUITE 300 BERWYN PA 19312
Business Address
Mathias Sheila (Reporting) CIK: 0001991182 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40064 | Film No.: 231301788